🇺🇸 FDA
Patent

US 7705177

Ketone compounds and compositions for cholesterol management and related uses

granted A61PA61P1/00A61P1/16

Quick answer

US patent 7705177 (Ketone compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P1/00, A61P1/16, A61P1/18, A61P13/12